Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer

International Journal of Molecular Medicine

Volumn 4, Issue 1, 1999, Pages 61-65

  Riese, Ulrike ^a   Dahse, Regine ^a   Wolfgangfiedler, ^b   Theuer, Claudia ^a   Koscielny, Sven ^c   Ernst, Günther ^a   Beleites, Eggert ^a   Uweclaussen, ^a   Von Eggeling, Ferdinand ^c  

^a Institute of Human Genetics and Anthropology   (Germany)

^b Clinic of ENT Diseases   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Head and neck cancer; Methylation; Mutation analysis; p16ISK41

Indexed keywords

DNA; PRIMER DNA;

ARTICLE; CHEMISTRY; DNA METHYLATION; EXON; GENETICS; HEAD AND NECK TUMOR; HUMAN; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; EXONS; GENES, P16; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 0033159463     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.4.1.61     Document Type: Article

References (32)

1. Scrrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
2. Liggett WH and Sidransky D: Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16: 1197-1206, 1998.
3. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37, 1996.
4. Stone S, Jiang P, Dayananth P, el a!: Complex structure and regulation of the PI6 (MTS1) locus. Cancer Res 55: 2988-2994, 1995.
5. Quelle DE, Ashmun RA, Hannon GJ, et al: Cloning and characterization of murinc p16INK4a and p15INK4b genes. Oncogenc 11:635-645, 1995.
6. Robertson KD and Jones PA: The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced b/DNA methylation and down-reeulated by wild-type p53. Mol Cell Biol 18: 6457-6473, 1998.
7. Prives C: Signaling to p53: breaking the MDM2-p53 circuit. ' Cell 95: 5-8, 1998.
8. Zhang YP, Xiong Y and Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734, 1998.
9. Reed AL, Califano J, Cairns P, et al: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633, 1996.
10. Papadimitrakopoulou V, Izzo J, Lippman SM, et al: Frequent inactivation of p16(INK4a) in oral premalignant lesions. Oncogene 14: 1799-1803, 1997.
11. Foulkes WD, Flanders TY, Pollock PM and Hayward NK: The CDKN2A (p16) gene and human cancer. Mol Med 3: 5-20, 1997.
12. Olshan AF, Wcisslcr MC, Pei H, et al: Alterations of the p16 gene in head and neck cancer: frequency and association with P53, PRAD-1 and HPV. Oncogene 14: 811-818, 1997.
13. Jarcs P, Fernandez PL, Nadal A, et al: p16MTSI/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx. Oncogene 15: 1445-1453, 1997.
14. Merlo A, Herman JG, Mao L, et al: 51 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSI in human cancers. Nat Med 1: 686-692, 1995.
15. Little M and Wainwright B: Methylation and p16: suppressing the suppressor. Nat Med 1: 633-634, 1995.
16. Gonzalez Zulucta M, Bender CM, Yang AS, et al: Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535, 1995.
17. Lagoda PJ, Seitz G, Epplen JT and Issinger OG: Increased detcctability of somatic changes in the DNA from human tumours after probing with 'synthetic' and 'genome-derived' hypervariable multilocus probes. Hum Genet 84: 35-40, 1989.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sei USA 93: 9821-9826, 1996.
19. Wick ST, Dubay MM, Imanil I and Brizuela L: Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16. Oncogene 11: 2013-2019, 1995.
20. Venkataramani R, Swaminathan K and Marmorstein R: Crystal structure of the CDK4/6 inhibitory protein p18(INK4c) provides insights into ankyrin-like repeat structure/function and tumor-derived p16(INK4) mutations. Nat Struct Biol 5: 74-81, 1998.
21. Russo AA, Tong L, Lee JO, Jeffrey PD and Pavletich NP: Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16(INK4a). Nature 395:237-243, 1998.
22. Hussussian CJ, Struewing JP, Goldstein AM, et al: Germline p16 mutations in familial melanoma. Nat Genet 8: 15-21, 1994.
23. Walker GJ, Hussussian CJ, Flores JF, et al: Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet 4: 1845-1852, 1995.
24. Heidenreich A, Gaddipati JP, Moul JW and Srivastava S: Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. J Urol 159: 1725-1730, 1998.
25. Ranade K, Hussussian CJ, Sikorski RS, et al: Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 10: 114-116, 1995.
26. Dawson CD, Chang KW and Solt DB: MTS1 gene mutations in archival oral squamous cell carcinomas. J Oral Pathol Med 25: 541-546, 1996.
27. Nakanishi H, Uzawa K, Yokoe H, et al: Rare mutations of the growth suppressor genes involved in negative regulation of the cell cycle: p15, p16 and p18 genes in oral squamous cell carcinoma. Int J Oncol 11: 1129-1133, 1997.
28. Sakata K: Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 25: 302-307, 1996.
29. Gonzalez MV, Pello MF, Lopez Larrea C, Suarez C, Mcncndez MJ and Goto E: Deletion and methylation of the tumour suppressor gene pl6/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol 50: 509-512, 1997.
30. Lang JC, Tobin FJ, Knobloch TJ, et al: Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope 108: 923-928, 1998.
31. El-Naggar AK, Lai SL, dayman G, et al: Methylation, a major mechanism of p!6/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151: 1767-1774, 1997.
32. Carey TE: Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann Med 28: 183-188, 1996.